MMP9 and myeloid sarcoma: Experimental results demonstrated the intrathecal synthesis of MMP-9 in MS10 and the increase of its levels in cerebrospinal fluid (CSF) and serum of MS patients affected by the relapsing-remitting (RR) form compared to the primary progressive form and healthy controls11,12.